We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin Gears Up for Q4 Earnings: What Surprise Awaits Investors?
Read MoreHide Full Article
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to register a decline in the top and bottom lines when it reports fourth-quarter 2024 earnings on Feb. 13. The Zacks Consensus Estimate for revenues is pegged at $441.1 million, indicating a decrease of 9.7% from the prior-year quarter’s figure.
Although the consensus mark for earnings has increased a penny in the past 30 days to 22 cents per share, the estimated figure indicates a decline of 40.5% from the year-ago quarter. NUS has a trailing four-quarter earnings surprise of 27.3%, on average.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Factors Likely to Impact NUS’ Q4 Results
Nu Skin has been battling a challenging operating environment, including inflationary pressures, political uncertainty and weak consumer sentiment in a few markets. The company has also been encountering pressures within the direct selling industry. These headwinds, along with the adverse currency fluctuations, are likely to have weighed upon its performance.
Last month, the company announced preliminary revenues for the fourth quarter of 2024, stating that the metric was at the upper end of its projected range. For the fourth quarter, Nu Skin had earlier projected revenues of $410-$445 million, indicating a 9-16% decline from the previous year’s reported figure. On its last earnings call, management had envisioned adjusted earnings to be in the band of 19-29 cents a share.
Nu Skin’s Rhyz business has been performing well. A focus on innovation, brand building and cost management has been aiding. Nu Skin has also been gaining from its key strategic pillars, Products, Programs and Platforms. Such factors are likely to have offered some cushion to the company’s performance.
What Our Model Unveils for NUS
Our proven model does not conclusively predict an earnings beat for Nu Skin this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Nu Skin currently has an Earnings ESP of +6.98% and a Zacks Rank #5 (Strong Sell).
The company is likely to register a decline in its top line when it reports fourth-quarter 2024 numbers. The Zacks Consensus Estimate for WK Kellogg’s quarterly revenues is pegged at $642.9 million, which implies a dip of 1.2% from the prior-year quarter.
The Zacks Consensus Estimate for WK Kellogg’s quarterly earnings per share is pegged at 25 cents, indicating a 38.9% increase from the year-ago period. The consensus mark for earnings has gone down a penny in the last 30 days. KLG delivered an earnings surprise of 19.2% in the last reported quarter.
Monster Beverage (MNST - Free Report) currently has an Earnings ESP of +0.84% and a Zacks Rank of 3. The company is expected to register top and bottom-line growth when it reports fourth-quarter 2024 results. Although the Zacks Consensus Estimate for MNST’s quarterly earnings has been stable in the last 30 days at 40 cents per share, the projection indicates 5.3% growth from the year-ago quarter's number.
Th consensus estimate for Monster Beverage’s quarterly revenues is pegged at $1.8 billion, implying a rise of 3.7% from the figure in the prior-year quarter. MNST reported a negative earnings surprise of 5.2%, on average, in the trailing four quarters.
The Coca-Cola Company (KO - Free Report) currently has an Earnings ESP of +0.30% and a Zacks Rank of 3. The Zacks Consensus Estimate for quarterly revenues is pegged at $10.69 billion, which indicates a decrease of 1.5% from the figure reported in the prior-year quarter.
The consensus estimate for Coca-Cola’s fourth-quarter 2024 EPS is pegged at 51 cents, which implies a 4.1% increase year over year. The consensus mark for earnings has gone down a penny in the last 30 days. KO has a trailing four-quarter earnings surprise of 3.9%, on average.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Nu Skin Gears Up for Q4 Earnings: What Surprise Awaits Investors?
Nu Skin Enterprises, Inc. (NUS - Free Report) is likely to register a decline in the top and bottom lines when it reports fourth-quarter 2024 earnings on Feb. 13. The Zacks Consensus Estimate for revenues is pegged at $441.1 million, indicating a decrease of 9.7% from the prior-year quarter’s figure.
Although the consensus mark for earnings has increased a penny in the past 30 days to 22 cents per share, the estimated figure indicates a decline of 40.5% from the year-ago quarter. NUS has a trailing four-quarter earnings surprise of 27.3%, on average.
Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.
Factors Likely to Impact NUS’ Q4 Results
Nu Skin has been battling a challenging operating environment, including inflationary pressures, political uncertainty and weak consumer sentiment in a few markets. The company has also been encountering pressures within the direct selling industry. These headwinds, along with the adverse currency fluctuations, are likely to have weighed upon its performance.
Last month, the company announced preliminary revenues for the fourth quarter of 2024, stating that the metric was at the upper end of its projected range. For the fourth quarter, Nu Skin had earlier projected revenues of $410-$445 million, indicating a 9-16% decline from the previous year’s reported figure. On its last earnings call, management had envisioned adjusted earnings to be in the band of 19-29 cents a share.
Nu Skin’s Rhyz business has been performing well. A focus on innovation, brand building and cost management has been aiding. Nu Skin has also been gaining from its key strategic pillars, Products, Programs and Platforms. Such factors are likely to have offered some cushion to the company’s performance.
What Our Model Unveils for NUS
Our proven model does not conclusively predict an earnings beat for Nu Skin this season. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that’s not the case here. You can uncover the best stocks before they’re reported with our Earnings ESP Filter.
Nu Skin currently has an Earnings ESP of +6.98% and a Zacks Rank #5 (Strong Sell).
Nu Skin Enterprises, Inc. Price and EPS Surprise
Nu Skin Enterprises, Inc. price-eps-surprise | Nu Skin Enterprises, Inc. Quote
Stocks With the Favorable Combination
Here are some companies, which according to our model, have the correct combination to beat on earnings this time around.
WK Kellogg (KLG - Free Report) currently has an Earnings ESP of +14.85% and a Zacks Rank of 3. You can see the complete list of today’s Zacks #1 Rank stocks here.
The company is likely to register a decline in its top line when it reports fourth-quarter 2024 numbers. The Zacks Consensus Estimate for WK Kellogg’s quarterly revenues is pegged at $642.9 million, which implies a dip of 1.2% from the prior-year quarter.
The Zacks Consensus Estimate for WK Kellogg’s quarterly earnings per share is pegged at 25 cents, indicating a 38.9% increase from the year-ago period. The consensus mark for earnings has gone down a penny in the last 30 days. KLG delivered an earnings surprise of 19.2% in the last reported quarter.
Monster Beverage (MNST - Free Report) currently has an Earnings ESP of +0.84% and a Zacks Rank of 3. The company is expected to register top and bottom-line growth when it reports fourth-quarter 2024 results. Although the Zacks Consensus Estimate for MNST’s quarterly earnings has been stable in the last 30 days at 40 cents per share, the projection indicates 5.3% growth from the year-ago quarter's number.
Th consensus estimate for Monster Beverage’s quarterly revenues is pegged at $1.8 billion, implying a rise of 3.7% from the figure in the prior-year quarter. MNST reported a negative earnings surprise of 5.2%, on average, in the trailing four quarters.
The Coca-Cola Company (KO - Free Report) currently has an Earnings ESP of +0.30% and a Zacks Rank of 3. The Zacks Consensus Estimate for quarterly revenues is pegged at $10.69 billion, which indicates a decrease of 1.5% from the figure reported in the prior-year quarter.
The consensus estimate for Coca-Cola’s fourth-quarter 2024 EPS is pegged at 51 cents, which implies a 4.1% increase year over year. The consensus mark for earnings has gone down a penny in the last 30 days. KO has a trailing four-quarter earnings surprise of 3.9%, on average.